Member Info for Elartu

https://twitter.com/haze2947/status/1155787033954177024

Balaji at the AI in Radiology meeting he attended. Starts talk at 03:30 approx. Note the Siemens Healthineers logo in the background early on.

https://www.expresshealthcare.in/healthcare-videos/radiology-videos/panel-discussion-on-artificial-intelligence-in-radiology-where-are-we-today-rad2024/413031/

All guessing Bob. I don't have time to do more than guess. I'd go for there being around 2 million left on the MM's books. Sounds a lot? Not really. Last time I checked there were 4-5 companies making a book in Feedback. Evenly spread, it would mean around 500k shares for each MM. That can easily go.

Do I think there are more shares to be sold? No. You know who I suspect is behind this and he likes to sell in round numbers until his last trade. Today's trade ended in '548' from memory. I reckon he's done for the time being.

No idea if these shares were 'borrowed' or not but if they were it would explain the lack of holdings RNS whilst accumulation was underway. Personally, I hope they were borrowed because there's a strong likelihood of him making a loss when he is required to hand them back.

Can't think of more to say right now. Hope it helps.

Doubtful as Feedback have applied for a patent. Doesn't look like Common Time can attach clinical standard images on their system either unless I missed it.

Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: a multicentre retrospective study

https://www.sciencedirect.com/science/article/abs/pii/S0720048X1930261X

Method

One hundred and four patients were enrolled from 3 different centers. CT was performed using similar parameters among different scanners. CTHA was performed with the proprietary software TexRAD, which extracts histogram features at different spatial scale (spatial scale filters, SSF) producing 30 CTHA features per patients. Cross-validated Least Absolute Shrinkage and Selection Operator LASSO was used to select those features which were related to overall and progression-free survival (OS and PFS, respectively). High- and low-risk subgroups were identified using the best cutoff.

Sell 750k at 0.71p (small amounts 0.72p)
Buy 150k at 0.7475p

Stumbled upon this tonight. Believe the following is a new addition.

Https://www.sinc.co.uk/member-directory/texrad

For Imaging and PACS OEMs:

* additional and unique product for all existing imaging clients (differentiator)

* novel technology with no current competition (patent applied for)

* software – no hardware modifications required

* offered as an add-on or software bundle

Limits currently are sell 500k at 0.72p, buy 350k at 0.739p.

I had a check on limits about 30 minutes ago and they were sell 750k at 0.765p, buy 150k at 0.845p so no sign of the big seller at present.

Very much doubt Tom Oakley can buy at the moment, he has something big to announce in September.

Dual-energy CT texture analysis with machine learning for the evaluation and characterization of cervical lymphadenopathy

https://www.sciencedirect.com/science/article/pii/S200103701830309X

All lymph nodes meeting inclusion criteria (Fig. 1, Fig. 2) were included in this study. Texture analysis was performed using a filtration-histogram technique with a commercially-available research software (TexRAD Ltd., Cambridge, United Kingdom) by manually delineating a region of interest (ROI) around the largest diameter of the lymph node in the axial plane.

Pity about the overhang.

Current on line limits are:
Sell 375k at 0.925p
Buy 3.75 mil at 1p (small amounts at 0.95p)

Current on line limits are:
Sell 375k at 0.7525p
Buy 2.5 mil at 0.8p (small amounts up to 600k at 0.7845p)

It's this overhang that is stopping any significant buying in my opinion.

One small buyer today.

Possibly is a closed period as accountants will be working on year end figures at present. If so, the directors may not be able to buy until accounts are announced.

That's exactly what the NHS is going to do. They will insist on their doctors using this. WhatsApp screen shots of medical images are not safe both in terms of medical precision nor data security. I confidently predict this will sweep through the NHS in double rapid time. After all NHS mistakes kill 11,000 people per year. That needs to be reduced. PDQ.

https://www.telegraph.co.uk/news/2019/07/01/nhs-blunders-claiming-11000-lives-every-year-amid-blame-game/

Very quick rehash of RNS available from Proactive Investors.

https://www.proactiveinvestors.co.uk/news/details/223653/feedback-chief-says-co-will--prioritise--cadran-product-as-focuses-on-secure-messaging-between-doctors-223653.html

Not the way I see it.

https://www.investegate.co.uk/feedback-plc--fdbk-/rns/outcome-of-strategic-review-and-trading-update/201907100700030522F/

None of this came from the board Chaz. It was 12th Man Solutions that posted the info.

https://twitter.com/12thManSolution/status/1148527944626823170